OBJECTIVE -There is conflicting evidence about whether nonwhite Americans with diabetes have an increased risk of cardiovascular disease (CVD). Because geographic region is known to influence the risk of CVD in the U.S., we sought to determine the effects of race and region on cardiovascular morbidity among elderly Americans with diabetes.
R
ace and ethnicity significantly influence the risk of cardiovascular disease (CVD) in the U.S. For example, black race is associated with increased mortality from ischemic heart disease (IHD) and stroke (1-3) compared with whites. Diabetes, a major risk factor for CVD (4) , affects black Americans disproportionately, and frequently, diabetes is not as well controlled in blacks as in whites (5) (6) (7) (8) . One might suspect, therefore, that blacks with diabetes would have excess CVD. Although one U.S. study (9) reported greater CVD prevalence among black geriatric patients with diabetes, others (10 -12) have not found excess CVD. In fact, blacks of African-Caribbean descent in the U.K. who have diabetes have been found to be at a lower risk of CVD than white Europeans with diabetes (13) . We previously found that heart failure incidence was similar between elderly blacks and whites with diabetes (14) , but neither that study nor the other U.S. studies cited have considered whether among individuals with diabetes the effect of race on CVD outcomes differs with geography. Cardiovascular mortality varies across the U.S., with the South having the highest rates for stroke and CVD mortality regardless of the racial group studied (15, 16) . The burden of diabetes also varies by region, with the South having the highest prevalence (17) . Accordingly, we hypothesized that the effect of race on risk of CVD among individuals with diabetes may vary by region. This report investigates, among the elderly with diabetes, black-white differences in the incidence of acute myocardial infarction (AMI), IHD, cerebrovascular accident (CVA; including both stroke and transient ischemic attack), and heart failure and evaluates the extent to which region influences any racial differences observed.
RESEARCH DESIGN AND METHODS
-Medicare is the government-financed medical insurance program for the elderly and disabled who contributed to the Social Security program in the U.S.; virtually all Americans aged Ն65 years are covered. We obtained data from the 5% Standard Analytical File, which contained Medicare claims for 1,941,453 beneficiaries in 1994. Details regarding the data collection have been published (18) . Race (by self-report at enrollment into Social Security), age, state of residence, and mortality information were as reported in the Medicare Denominator File. After excluding subjects aged Ͻ65 years and those older who died in 1994, there were 1,551,586 beneficiaries age Ն65 years alive through 1 January 1995. We further excluded 31,151 (2.0%) who did not live in the U.S., 92,818 (6.0%) who were not enrolled in both Medicare Part A (inpatient) and Part B (outpatient), and 142,964 (9.2%) who were enrolled in a health maintenance organization (HMO) in 1994 (and thus utilization claims are not available). Among the 1,284,653 remaining, individuals were classified as having diabetes if, in 1994, there were at least two Part B claims or one hospitalization claim with a diabetes-related ICD-9 diagnosis code (250.xx). This classification yielded 151,523 individuals with diabetes. Of this group, we excluded 4,404 subjects who identified themselves as Hispanic, Asian, Native American, or other race (their numbers were insufficient to compare them with whites by sex or region) and 3,004 with missing race/ethnicity data, resulting in a cohort of 126,153 white and 17,962 black older adults with diabetes. To assess representativeness, we compared the demographic characteristics of this cohort with the 1990 U.S. Census population aged Ն65 years (19) .
Subjects were considered to have prevalent heart failure, AMI, IHD, or CVA if one or more inpatient or outpatient claims were found in 1994 with an ICD-9 code (online appendix [available at http:// care.diabetesjournals.org]) indicating that disease; prevalent CVD was defined as one claim for any of these diagnoses. For a given incidence analysis, we first excluded subjects with that disease in 1994. We then identified the first CVD claim occurring after 1 January 1995. The date of CVD was the midpoint of the quarter in which the claim was filed, unless the participant also died in that quarter, in which case the date of CVD was the minimum of the midpoint of the interval or the date of death. Participants were censored if they died (censored on date of death) or joined an HMO (assessed annually, censored date 31 December of year before joining the HMO) before experiencing an end point. Follow-up extended until 31 December 1999. Comorbidities were defined as the presence, in 1994, of at least one claim containing a diagnosis code for hypertension, nephropathy, retinopathy, or neuropathy (online appendix); additionally, we identified individuals also enrolled in Medicare's end-stage renal disease program. The U.S. was divided into four regions (south, west, midwest, and northeast) based on state groupings in the Census. For ease of presentation, we dichotomized the regions into south and "other regions" because preliminary analyses indicated that the major differences in patterns of CVD incidence were between the South and the other regions.
Analysis
2 Tests were used to assess racial differences in comorbidities and prevalence of CVD at baseline, and a Wilcoxon's ranksum test was used to compare the age distributions. We used survival analysis to calculate event rates, assuming persontime accrued from 1 January 1995 to the date of event or the censored date. Incidence rates were estimated as 100 times the number of events divided by the person-years of exposure. Kaplan-Meier methods were used to obtain 1-and 5-year disease-free survival estimates for blacks and whites separately for strata defined by region and sex. Log-rank tests were used to assess the effect of race on survival. Cox's proportional hazards regression was used to calculate the adjusted hazard ratio for blacks versus whites for each incident CVD event. Models included interaction terms for race by geographic region and race by sex. A stratified analysis (yearly age strata up to age 84, then 85-89, and Ն90 years) was used to ensure unbiased estimates for the race effect (20) . Given the fine stratification used, the results obtained were almost identical to those obtained from an alternative model using age as the time scale and stratifying by age at baseline. Other covariates included sex, region, and baseline values for comorbidities. All significance tests were two tailed. Analyses were performed using SAS (SAS 8.2; SAS Institute, Cary, NC).
RESULTS

Baseline characteristics
The sex distribution was similar, but the racial distribution differed from the characteristics of the U.S. population aged Ն65 years in the 1990 census (60% women; 89% white, 8% black, and 3% other). The characteristics of black and white Medicare beneficiaries meeting our selection criteria are presented in Table 1 . Blacks were slightly younger than whites (mean age 73.8 vs. 74.5 years, P Ͻ 0.001). Renal disease, hypertension, and retinopathy were more common among blacks. Blacks were slightly more likely to have had a prior stroke, while whites were more likely to have had an AMI and IHD. Data are n (%). All differences are statistically significant at P Ͻ 0.001, except for *P Ͻ 0.05 and †not significantly different.
Incident CVD
After excluding subjects with prevalent disease, the median follow-up time was 2.6 years for IHD and 2.1 years for any CVD. The incidence rate of AMI was lower in blacks (4.0/100 person-years) than whites (4.8/100 person-years); a similar pattern was noted for IHD (blacks 15.7/100 person-years, whites 17.5/100 person-years) (both log rank P Ͻ 0.001). The rates were more similar for the other conditions (CVA, blacks 13.0/100 person-years, whites 12.8/100 person-years; heart failure, blacks 13.1/100 personyears, whites 12.9/100 person-years). When we examined rates by race and region, for most diagnoses we noted a lower rate for blacks, particularly women, in the South, compared with the other regions. Formal tests for interactions (see RESEARCH DESIGN AND METHODS) were significant for all diagnoses. The cumulative 5-year Kaplan-Meier incidence estimates of IHD by race, region, and sex ( Fig. 1 ) are illustrative of this interaction, demonstrating differential incidence by race according to sex and region. Because of these interactions, stratified incidence rates are presented in Table 2 . The incidence rates of AMI, IHD, and heart failure were generally lower among the four race/sex groups in the South than in their counterparts in the rest of the U.S. The incidence rate of CVA was higher in the South for white men and women and was lower in the South for black women. Southern blacks had lower rates of AMI, IHD, and CVA than southern whites. Southern black and white men and women have similar rates of heart failure. Additionally, black men in the other regions tend to have lower rates of disease than white men in the same regions, whereas black women in the other regions tend to have higher rates than the corresponding white women. The incidence of any CVD was slightly lower in the South.
Multivariate models
The results of the Cox's proportional hazards regressions for CVD outcomes, simultaneously adjusting for comorbidities, age, sex, and region, are shown in Table 3 . The comorbidities considered were significantly associated with an increased risk of each outcome. Because of the interactions present, the sex and region effects are presented by race; the race effect is presented by subgroups of region and sex. Among whites, being male conferred a 6 -28% increased risk of the individual outcomes and a 10% (95% CI 8 -13) increased risk of any CVD outcome. In contrast, among blacks, being male conferred an increased risk only for AMI. Blacks liv- ing in the South (versus blacks in other regions) had a 9 -28% lower risk of the individual CVD outcomes. Among whites, residence in the South was protective only against AMI (6% lower risk) and IHD (5% lower risk); in contrast, southern whites had a 9% higher risk of stroke. The effect of race in the South was, for black men, a 31% lower risk of AMI and a 26% lower risk of IHD than their white counterparts, while southern black women had a 20% lower risk of AMI and a 16% lower risk of IHD than southern white women. For any CVD event, black women in the South were at 5% lower risk than their white peers; the risk for southern black men was 13% lower than for whites. In contrast, in other regions, the effect of black race among women was an increased risk of IHD (11%), heart failure (6%), CVA (12%), or any CVD (10%). Among non-southern men, a lower risk among blacks was only seen for AMI (17%).
CONCLUSIONS -In a large cohort of elderly Medicare beneficiaries with diabetes who received care on a fee-forservice basis, we observed a substantial incidence of CVD among all sex/age/ regional groups examined. We found some evidence supporting our hypothesis that there are regional differences in the effect of race on the risk of CVD among individuals with diabetes. Outside the South, black women had a small but significantly higher incidence than white women of any CVD and of IHD, heart failure, and CVA specifically; but inside the South, black women had a lower incidence of each CVD event (and of any CVD) than white women. Patterns for men also differed by region, as southern black men were always at less risk than white men for CVD, but outside the South there was a difference by race only for AMI (where black men were at lower risk).
Considerable data suggest that blacks with diabetes have worse control of glucose and blood pressure than whites (6, 7, 21) . Worse control glucose of glycemia and blood pressure is associated with an increased risk of CVD events and suggest that there should be a much higher rate of CVD in blacks than in whites (22, 23) . Despite this, we did not find a substantially increased risk of CVD among black Medicare fee-for-service patients when we compared them with whites; as noted, in the South there was actually an advantage conferred by black race in all comparisons. We did find a modestly increased risk (range 6 -12%) for black women in non-southern regions. This is in contrast to earlier reports utilizing data from one California HMO, the Veterans Health Administration, as well as national health statistics that found that blacks with diabetes were not at greater risk than whites (11, 12, 24, 25) . We previously found no significant difference in the risk of heart failure by race overall (14) ; however, in the present study, when we took into account region and sex, we found a marginally lower risk of heart failure in southern black men and women than in their white counterparts. Our failure in the present study (except for women in other regions) to find a greater risk of CVA in blacks is consistent with one prior report (11) . We are not aware of other reports examining differences in CVD outcomes among American populations with diabetes that have demonstrated variation by race and region. Although we found a protective effect of southern residence for blacks and a detrimental effect of nonsouthern residence for black women, these findings should be accepted with caution. The apparent protective effect of black race in the South may be due to survivor bias if southern blacks with diabetes tend to develop CVD and die before becoming eligible for Medicare. Alternatively, there may be racial variation between the South and elsewhere in terms of the diagnosis of AMI or IHD or at least in the choice of ICD-9 codes. Differential CVD risk by region may also reflect differences in unmeasured CVD risk factors and health behaviors such as smoking, diet, control of diabetes, hypertension, or dyslipidemia. Our findings are not likely due to systematically better control of these risk factors in blacks versus whites, since the preponderance of evidence suggests blacks have both worse quality of diabetes care and control of risk factors for CVD (5) (6) (7) (8) 21) .
The chief strengths of this analysis are the use of a large, longitudinal dataset with a population representative of older Americans with diabetes, inclusion of geographic region into the study, and the use of regression models incorporating several variables to address differences in risk of CVD. The dataset allowed us to precisely quantify even small differences in risk between subgroups defined by sex, region, and race. The main limitation is the use of claims data for all aspects of this work, including the determination of outcomes as well as the covariates. Furthermore, age, sex, and race were not independently verified. These limitations raise concerns regarding misclassification. Our criteria for diabetes using Medicare claims were reported to have a specificity of 98% (26) . High specificity for many diagnoses including IHD and CVA has been reported when comparing claims to clinical records (27) . In addition, while we excluded those with a 1994 claim for CVD in incidence analyses, we could not ascertain which individuals had had a CVD claim before 1994. The most likely effects of the limitations are to make less precise the incidence data and an obscuring of associations between predictor variables and the outcomes of interest, which would likely cause us to underestimate the true effects of these variables. Another limitation is our inability to evaluate additional factors related to cardiovascular risk, including the duration, severity, or control of diabetes, smoking, or hyperlipidemia.
How best to explain the greater risk for CVD of black women with diabetes not residing in the South (versus white women with diabetes) is open to question. The finding of a regional effect argues against any genetic explanation and suggests that regional differences in lifestyle, environment, or quality of care may play some role. We note, however, that among the elderly with diabetes, CVD occurs frequently regardless of race, sex, or region. We also point out that while many comparisons reach statistical significance, this was often abetted by large samples, and the differences observed are quite small in magnitude. The high incidence of CVD demonstrated among the elderly with diabetes is especially concerning given the recent trends in diabetes incidence in the elderly (28) . The aging of the U.S. population and the high risk of diabetes in older people make prevention of diabetes and its complications a high priority.
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